> Skip repeated content

Intra-articular Corticosteroid Injection for Idiopathic Adhesive Capsulitis of the Shoulder

IRB Number: 27020
inactive

July 31, 2007

Institutional Review Board, Hospital for Special Surgery

The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.

For further information, see Understanding Clinical Trials/Research Studies.

Principal Investigator

 

Jennifer L. Solomon, MD

Co-Investigators

 

Jo A. Hannafin, MD, PhD
Scott A. Rodeo, MD
Beth E. Shubin Stein, MD
Lisa R. Callahan, MD
Ronald S. Adler, MD, PhD
Shikha Sethi, MD

Summary

The physicians in this study are seeking a total of one hundred patients to participate over the course of one year.  Following initial diagnosis by the physician, you will be asked to participate in fifteen minute phone call surveys for a total of 6 times during the course of the year.

Inclusion/Exclusion Criteria

If you have had pain or loss of motion in your shoulder lasting nine months or less, one of the investigating physicians may examine you to determine whether you have a condition called adhesive capsulitis.  After this, your physician can further determine your eligibility for participation in this study.

Contact Information

Jennifer Solomon, MD
212.606.1720